Using eye-tracking to improve early detection of Alzheimer's disease
Multimodal Deep Learning to Assess Cognitive Processes and a Validation of a Visuospatial Memory Eye-Tracking Test in Diverse Populations
This study is testing a new eye-tracking test called VisMET to see if it can help spot early signs of Alzheimer's disease in older adults, whether they have memory issues or not, and aims to make diagnosing the condition easier for everyone.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-11170825 on NIH RePORTER |
What this research studies
This research investigates a new digital test called the Visuospatial Memory Eye-Tracking Test (VisMET) that aims to detect early signs of Alzheimer's disease (AD) by monitoring eye movements. The study will evaluate how well VisMET can identify subtle memory impairments in older adults, regardless of their race, sex, or education level. Participants will include older adults with and without cognitive impairment, and the findings could lead to more equitable and accessible methods for diagnosing AD. The research will be conducted at Emory University and will involve collaboration with a diverse national cohort.
Who could benefit from this research
Good fit: Ideal candidates for this research include older adults, particularly those who may be experiencing early signs of cognitive decline.
Not a fit: Patients with advanced Alzheimer's disease or those who do not have any cognitive impairment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier and more accurate detection of Alzheimer's disease, allowing for timely interventions.
How similar studies have performed: Previous research has shown promise in using digital biomarkers for detecting cognitive decline, making this approach a potentially valuable advancement in Alzheimer's detection.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Clifford, Gari David — Emory University
- Study coordinator: Clifford, Gari David
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.